Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LNX1 antisense RNA 1 (LNX1-AS1) is a long non-coding RNA (lncRNA) transcribed from the opposite strand of the LNX1 gene locus on chromosome 4[1][7][9]. As an antisense RNA, it does not code for protein, but instead acts through RNA-mediated regulatory mechanisms. Antisense lncRNAs like LNX1-AS1 are generally involved in the regulation of gene expression, potentially by modulating their sense gene (in this case, LNX1), altering chromatin structure, impacting transcription, or engaging in other RNA-based regulatory functions[4]. Although there is extensive evidence for functional roles of antisense lncRNAs in development, epigenetic regulation, and disease (especially cancer), no direct evidence currently links LNX1-AS1 itself to any established therapeutic role, mechanism, or specific pathophysiological process[1][9]. Its classification is as a non-protein-coding RNA of the antisense type.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LNX1 antisense RNA 1 (LNX1-AS1).